Lower CVD Risk With Stable DMARD Therapy in Seropositive RA

Patients with seropositive RA on stable DMARD therapy showed a CVD risk comparable with that of the general population, unlike those whose treatment regimen was not stable.
Medscape Medical News

source https://www.medscape.com/viewarticle/lower-cvd-risk-stable-dmard-therapy-seropositive-rheumatoid-2024a10008g8?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?